KALA BIO, Inc.
KALA
$0.93
-$0.18-15.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.35% | 1.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.97% | 2.13% | |||
| Operating Income | 1.97% | -2.13% | |||
| Income Before Tax | 32.19% | -24.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.19% | -24.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.19% | -24.68% | |||
| EBIT | 1.97% | -2.13% | |||
| EBITDA | 2.54% | -2.16% | |||
| EPS Basic | 37.29% | -21.48% | |||
| Normalized Basic EPS | 7.65% | -20.10% | |||
| EPS Diluted | 37.29% | -21.48% | |||
| Normalized Diluted EPS | 7.65% | -20.10% | |||
| Average Basic Shares Outstanding | 8.13% | 2.63% | |||
| Average Diluted Shares Outstanding | 8.13% | 2.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||